ARCHIVES

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

September 27, 2002

Yarbro Refuses To Seek Core Renewal, Quits Director Post

September 22, 1978

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008

Bennett Of NYU Heads NCI Director Search Committee

March 11, 1977